Chronic heart failure and the immune system

Daniela Mari1, Federica Di Berardino, Massimo Cugno

  • 1Department of Internal Medicine, University of Milan, Maggiore Hospital IRCCS, Via Pace 15, 20122 Milan, Italy. daniela.mari@unimi.it

Insights

Immune system activation, involving cytokines and chemokines, plays a key role in chronic heart failure (CHF) progression. Research explores gut or heart origins of this inflammation, suggesting new anti-cytokine therapies for CHF.

Area of Science:

  • Cardiology
  • Immunology
  • Pathophysiology

Background:

  • Chronic heart failure (CHF) pathogenesis involves immune mechanisms.
  • Proinflammatory cytokines, chemokines, adhesion molecules, autoantibodies, nitric oxide (NO), and endothelin-1 are implicated in CHF progression.
  • The precise origin of immune activation in CHF remains unclear.

Purpose of the Study:

  • To investigate the role of immune mechanisms in chronic heart failure (CHF).
  • To explore potential sources of immune activation in CHF.
  • To identify new therapeutic strategies for CHF based on immune system modulation.

Main Methods:

  • Review of existing experimental and clinical data on immune involvement in CHF.
  • Analysis of proposed hypotheses regarding the origin of immune activation (gut vs. heart).
  • Consideration of systemic hypoxia as a contributing factor to immune activation.

Main Results:

  • Evidence supports immune system involvement in CHF, including cytokines (interleukin-1, -2, -6, tumor necrosis factor) and chemokines.
  • Two main hypotheses for immune activation: bacterial translocation from bowel edema or cytokine production by the failing heart.
  • Systemic hypoxia is identified as a potent stimulus for immune activation and cytokine production in CHF.

Conclusions:

  • The immune system, particularly cytokines, is crucial in CHF pathogenesis.
  • Neither gut nor heart alone fully explains the systemic inflammation in CHF; a multifactorial origin is likely.
  • Targeting immune pathways, such as with anti-cytokine drugs, offers promising therapeutic avenues for CHF.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...